Effect of blockade of endogenous angiotensin II on baroreflex function in conscious diabetic rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 5 53-5, 2003, Pages

  Maliszewska Scislo, Maria ^a,c   Scislo, Tadeusz J ^c   Rossi, Noreen F ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF GDA SK   (Poland)

Author keywords

Baroreceptors; Enalapril; Heart rate; Losartan; Renal sympathetic nerve activity

Indexed keywords

ANGIOTENSIN; CITRIC ACID; ENALAPRIL; LOSARTAN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRADYCARDIA; CONTROLLED STUDY; DIABETES MELLITUS; HEART RATE; KIDNEY NERVE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SYMPATHETIC TONE;

EID: 0345269106     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00578.2002     Document Type: Article

References (47)

1. Allan DR, McKnight JA, Kifor I, Coletti CM, and Hollenberg NK. Converting enzyme inhibition and renal tissue angiotensin II in the rat. Hypertension 24: 516-522, 1994.
2. Andersen S, Tarnow L, Rossing P, Hansen BV, and Parving HH. Renoprotective effects of angiotensin II blockade in type I diabetic patients with diabetic nephropathy. Kidney Int 57: 601-606, 2000.
3. Anderson S. Role of local and systemic angiotensin in diabetic renal disease. Kidney Int 52: S107-S110, 1997.
4. Bendle DR, Malpas SC, and Head GA. Role of endogenous angiotensin II on sympathetic reflexes in conscious rabbits. Am J Physiol Regul Integr Comp Physiol 272: R1816-R1825, 1997.
5. Bennett T, Farquhar IK, Hosking DJ, and Hampton JR. Assessment of methods for estimating autonomic nervous control of the heart in patients with diabetes mellitus. Diabetes 27: 1167-1174, 1978.
6. Bennett T, Hosking DJ, and Hampton JR. Baroreflex sensitivity and responses to the Valsalva manoeuvre in subjects with diabetes mellitus. J Neurol Neurosurg Psychiatry 39: 178-183, 1976.
7. Bishop VS and Sanderford MG. Angiotensin II modulation of the arterial baroreflex: role of the area postrema. Clin Exp Pharmacol Physiol 27: 428-431, 2000.
8. Brands MW and Fitzgerald SM. Arterial pressure control at the onset of type I diabetes: the role of nitric oxide and the renin-angiotensin system. Am J Hypertens 14:126S-131S, 2001.
9. Bunag RD, Tomita T, and Sasaki S. Streptozotocin diabetic rats are hypertensive despite reduced hypothalamic responsiveness. Hypertension 4: 556-565, 1982.
10. Caviezel F, Picotti GB, Margonato A, Slaviero G, Galva MD, Camagna P, Bondiolotti GP, Carruba MO, and Pozza G. Plasma adrenaline and noradrenaline concentrations in diabetic patients with and without neuropathy at rest and during sympathetic stimulation. Diabetologia 23: 19-23, 1982.
11. Chang KSK and Lund DD. Alterations in the baroreceptor reflex control of heart rate in streptozotocin diabetic rats. J Mol Cell Cardiol 18: 617-624, 1986.
12. Dall'Ago P, Fernandes TG, Machado UF, Bello AA, and Irigoyen MC. Baroreflex and chemoreflex dysfunction in streptozotocin-diabetic rats. Braz J Med Biol Res 30: 119-124, 1997.
13. Dibner-Dunlap M, Smith MI Kinugawa T, and Thames MD. Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure. J Am Coll Cardiol 27: 358-364, 1996.
14. DiBona G, Jones SY, and Brooks VL. ANG II receptor blockade and arterial baroreflex regulation of renal nerve activity in cardiac failure. Am J Physiol Regul Integr Comp Physiol 269: R1189-R1196, 1995.
15. DiBona GF, Jones SY, and Sawin LL. Effect of endogenous angiotensin II on renal nerve activity and its arterial baroreflex regulation. Am J Physiol Regul Integr Comp Physiol 271: R361-R367, 1996.
16. Dowell RT, Atkins FL, and Love S. Integrative nature and time course of cardiovascular alterations in the diabetic rat. J Cardiovasc Pharmacol 8: 406-413, 1986.
17. Eckberg DL, Harkins SW, Fritsch JM, Musgrave GE, and Gardner DF. Baroreflex control of plasma norepinephrine and heart period in healthy subjects and diabetic patients. J Clin Invest 78: 366-374, 1986.
18. Erdos EG and Skidgel RA. The angiotensin I converting enzyme. Lab Invest 56: 345-348, 1987.
19. Ewing DJ, Campbell IW, and Clarke BF. The natural history of diabetic autonomic neuropathy. QJM 49: 95-108, 1980.
20. Farah VM, Moreira ED, Pires MD, Irigoyen MC, and Krieger EM. Comparison of three methods for the determination of baroreflex sensitivity in conscious rats. Braz J Med Biol Res 32: 361-369, 1999.
21. Gaudet E, Godwin SJ, and Head GA. Effects of central infusion of angiotensin II and losartan on baroreflex control of heart rate in rabbits. Am J Physiol Heart Circ Physiol 278: H558-H566, 2000.
22. Guo GB and Abboud FM. Angiotensin II attenuates baroreflex control of heart rate and sympathetic activity. Am J Physiol Heart Circ Physiol 246: H80-H89, 1984.
23. Hartmann JF, Szemplinski M, Hayes NS, Keegan ME, and Slater EE. Effects of the angiotensin converting enzyme inhibitor, lisinopril, on normal and diabetic rats. J Hypertens 6: 677-683, 1988.
24. Head GA and Mayorov DN. Central angiotensin and baroreceptor control of circulation. Ann NY Acad Sci 940: 361-390, 2001.
25. Hicks KK, Seifen E, Stimers JR, and Kennedy RH. Effects of streptozotocin-induced diabetes on heart rate, blood pressure and cardiac autonomic nervous control. J Auton Nerv Syst 69: 21-30, 1998.
26. Jackson CV and Carrier GO. Influence of short-term experimental diabetes on blood pressure and heart rate in response to norepinephrine and angiotensin II in the conscious rat. J Cardiovasc Pharmacol 5: 260-265, 1983.
27. Kessler I. Mortality experience of diabetic patients. A twenty-six-year follow-up study. Am J Med 51: 715-724, 1971.
28. Kikkawa R, Kitamura E, Fujiwara Y, Haneda M, and Shigeta Y. Biphasic alteration of renin-angiotensin-aldosterone system in streptozotocin-diabetic rats. Renal Physiol 9: 187-192, 1986.
29. Kocks M, Buikema H, de Zeeuw D, and Navis G. Effect of sodium intake on vascular tissue ACE function during ACEi may explain sodium-induced therapy resistance to ACEi (Abstract). J Am Soc Nephrol 13: 334A, 2002.
30. Kumagai K and Reid IA. Angiotensin II exerts differential actions on renal nerve activity and heart rate. Hypertension 24: 451-456, 1994.
31. Lewis EJ, Hunsicker LG, Bain RP, and Rohde RD. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456-1462, 1993.
32. Li Z, Bains JS, and Ferguson AV. Functional evidence that the angiotensin antagonist losartan crosses the blood-brain barrier in the rat. Brain Res Bull 30: 33-39, 1993.
33. Lishner M, Akserrod S, Avi VM, Oz O, Divon M, and Ravid M. Spectral analysis of HR fluctuation: a non-invasive, sensitive method for the early diagnosis of autonomic neuropathy in diabetes mellitus. J Auton Nerv Syst 19: 119-125, 1987.
34. Maeda CY, Fernandes TG, Lulhier F, and Irigoyen MC. Streptozotocin diabetes modifies arterial pressure and baroreflex sensitivity in rats. Braz J Med Biol Res 28: 497-501, 1995.
35. Maeda CY, Fernandes TG, Timm HB, and Irigoyen MC. Autonomic dysfunction in short-term experimental diabetes. Hypertension 26: 1100-1104, 1995.
36. McDowell TS, Chapleau MW, Hajduczok G, and Abboud FM. Baroreflex dysfunction in diabetes mellitus. I. Selective impairment of parasympathetic control of heart rate. Am J Physiol Heart Circ Physiol 266: H235-H243, 1994.
37. McDowell TS, Hajduczok G, Abboud FM, and Chapleau MW. Baroreflex dysfunction in diabetes mellitus. II. Site of baroreflex impairment in diabetic rabbits. Am J Physiol Heart Circ Physiol 266: H244-H249, 1994.
38. Navarro X, Kennedy WR, and Ferrer MT. Cardiovascular responses to tilting in healthy and diabetic subjects. JNeurol Sci 104: 39-45, 1991.
39. Ohtani N, Ohta M, and Sugano T. Microdialysis study of modification of hypothalamic neurotransmitters in streptozotocin-diabetic rats. J Neurochem, 69: 1622-1628, 1997.
40. Patel KP and Zhang PL. Baroreflex function in streptozotocin (STZ) induced diabetic rats. Diabetes Res Clin Pract 27: 1-9, 1995.
41. Petersen JS and DiBona GF. Furosemide elicits immediate sympathoexcitation via a renal mechanism independent of angiotensin II. Pharmacol Toxicol 76: 106-113, 1995.
42. Ramanadham S and Tenner TE Jr. Alterations in cardiac performance in experimentally-induced diabetes. Pharmacology 27: 130-139, 1983.
43. Stornetta RL, Guyenet PG, and McCarty RC. Autonomic nervous system control of heart rate during baroreceptor activation in conscious and anesthetized rats. J Auton Nerv Syst 20: 121-127, 1987.
44. Ustundag B, Cay M, Naziroglu M, Dilsiz N, Crabbe MJC, and Ilhan N. The study of renin-angiotensin-aldosterone in experimental diabetes mellitus. Cell Biochem Funct 17: 193-198, 1999.
45. Valentovic M, Elliott CW, and Bell JG. The effect of streptozotocin-induced diabetes and insulin treatment on angiotensin converting enzyme activity. Res Commun Chem Pathol Pharmacol 58: 27-39, 1987.
46. Van Dyk DJ, Erman A, Erman T, Chen-Gal B, Sulkes J, and Boner G. Increased serum angiotensin converting enzyme activity in type I insulin-dependent diabetes mellitus: its relation to metabolic control and diabetic complications. Eur J Clin Invest 24: 463-467, 1994.
47. Yoshida T, Nishioka H, Nakamura Y, and Kondo M. Reduced noradrenaline turnover in streptozotocin-induced diabetic rats. Diabetologia 28: 692-696, 1985.